INS and Insulin resistance: Moreover, 2-hydroxybutyric acid, a marker of insulin resistance [19], was elevated after treatment with glimepiride but decreased on liraglutide treatment, possibly suggesting increased insulin resistance in the glimepiride group, and/or improved insulin sensitivity in the liraglutide group.